Concepedia

Terry D. Crawford

TD

21

Publications

1.2K

Citations

19

H-Index

1984

Active since

Affiliations

WuXi AppTec (China)(Current)

Constellation Pharmaceuticals (United States)

Terry D. Crawford is an author at WuXi AppTec (China) specializing in medicine, natural sciences, and drug discovery.

Top concepts

MedicineNatural SciencesDrug DiscoveryBiochemistryPharmacologyMedicinal ChemistryDrug DevelopmentChemical BiologyCell BiologyMolecular Biology

Publications per year

1984–2022

21

Publications

21

Disrupting Acetyl-Lysine Recognition: Progress in the Development of Bromodomain Inhibitors

F. Anthony Romero, Alexander M. Taylor, Terry D. Crawford et al. · Journal of Medicinal Chemistry · 2015 · 188 citations · Full text

Drug Target, Pharmacotherapy, Pharmaceutical Chemistry +18

GNE-781, A Highly Advanced Potent and Selective Bromodomain Inhibitor of Cyclic Adenosine Monophosphate Response Element Binding Protein, Binding Protein (CBP)

F. Anthony Romero, Jeremy Murray, Kwong Wah Lai et al. · Journal of Medicinal Chemistry · 2017 · 125 citations · Full text

Diving into the Water: Inducible Binding Conformations for BRD4, TAF1(2), BRD9, and CECR2 Bromodomains

Terry D. Crawford, Vickie Tsui, E. Megan Flynn et al. · Journal of Medicinal Chemistry · 2016 · 117 citations · Full text

Molecular Biology, Chemical Biology, Pharmaceutical Chemistry +17

Fragment-Based Discovery of a Selective and Cell-Active Benzodiazepinone CBP/EP300 Bromodomain Inhibitor (CPI-637)

Alexander M. Taylor, Alexandre Côté, Michael C. Hewitt et al. · ACS Medicinal Chemistry Letters · 2016 · 111 citations · Full text

Drug Target, Chemical Biology, Cancer Biology +16

Discovery of a Potent and Selective in Vivo Probe (GNE-272) for the Bromodomains of CBP/EP300

Terry D. Crawford, F. Anthony Romero, Kwong Wah Lai et al. · Journal of Medicinal Chemistry · 2016 · 94 citations · Full text

Rows per page

1–5 of 21